Gabapentin Capsules   3

Background
The solicitation is for the procurement of Gabapentin Capsules by the Department of Veterans Affairs (VA) and the Department of Defense (DoD) through their respective Pharmaceutical Prime Vendor (PPV) Programs. The purpose of this solicitation is to establish a supply source that will provide the drugs listed in the schedule for purchase through the PPV Programs. The total annual estimated usage for VA, Federal Health Care Center (FHCC), State Veterans Homes (SVH) - Option 2, DoD, Indian Health Service (IHS), and Bureau of Prisons (BOP) appears on the Schedule of Supplies section of this Solicitation.

Work Details
The specific products to be procured are Gabapentin 100mg Capsules in different quantities and packaging options. The solicitation requires offerors to submit prices for the base year and all four one-year options for all line items. Offered prices must include a Cost Recovery Fee of 0.5% and must not exceed two decimal places. Additionally, offerors must list an 11-digit National Drug Code (NDC) number for each offered drug that is unique to the offeror's company as outlined in the scope of contract.

Period of Performance
The contract effective date will be determined at the time of contract award. The implementation period will be a maximum of 60 days if awarded after September 11, 2023, and will end on November 10, 2023 if awarded prior to that date. The base year Ordering Period will be in effect for one year.

Place of Performance
The products will be delivered to various facilities/agencies including all Department of Veterans Affairs (VA) facilities, all Ordering Activities under the Department of Defense (DoD) Pharmaceutical Prime Vendor Program, Indian Health Service (IHS) facilities, Bureau of Prisons (BOP) facilities, Captain James A. Lovell Federal Health Care Center (FHCC), and all Option 2 State Veteran Homes.